TAM
RGLS
Tocqueville Asset Management’s Regulus Therapeutics RGLS Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-113,250
| Closed | -$374K | – | 846 |
|
|
2016
Q3 | $374K | Sell |
113,250
-900
| -0.8% | -$2.77K | ﹤0.01% | 676 |
|
|
2016
Q2 | $330K | Sell |
114,150
-19,300
| -14% | -$55.9K | ﹤0.01% | 707 |
|
|
2016
Q1 | $925K | Sell |
133,450
-3,800
| -3% | -$26.6K | 0.01% | 514 |
|
|
2015
Q4 | $1.2M | Sell |
137,250
-3,700
| -3% | -$32.4K | 0.02% | 509 |
|
|
2015
Q3 | $922K | Buy |
140,950
+96,250
| +215% | +$629K | 0.01% | 576 |
|
|
2015
Q2 | $490K | Buy |
44,700
+16,800
| +60% | +$184K | 0.01% | 724 |
|
|
2015
Q1 | $473K | Sell |
27,900
-11,700
| -30% | -$197K | 0.01% | 727 |
|
|
2014
Q4 | $635K | Buy |
+39,600
| New | +$635K | 0.01% | 661 |
|
|
2014
Q3 | – | Sell |
-68,500
| Closed | -$551K | – | 1178 |
|
|
2014
Q2 | $551K | Buy |
68,500
+4,500
| +7% | +$36.7K | 0.01% | 699 |
|
|
2014
Q1 | $577K | Buy |
64,000
+28,000
| +78% | +$252K | 0.01% | 545 |
|
|
2013
Q4 | $266K | Buy |
36,000
+5,000
| +16% | +$37.2K | ﹤0.01% | 739 |
|
|
2013
Q3 | $292K | Buy |
+31,000
| New | +$292K | ﹤0.01% | 780 |
|